Inside the Huddle
Disclosed transactions made within 30 days of substantive committee work — a markup or hearing — in the traded company's sector, by a member who sits on that committee. Every row shows the window and the jurisdiction that produced it.
What this page is, exactly. It reports a coincidence in time and subject matter between two public records: a filed transaction and a committee's own published calendar. It does not assert that one caused the other, that the member knew anything, or that anything improper occurred. Members of Congress trade securities legally. The window, the committee, and the jurisdiction basis are all shown so you can judge the coincidence yourself — and the original filing and the committee record are one click away on every row.
5 trade × committee-day pairings within ±30 days.
| Window | Trade date | Member | Ticker | Action | Amount (as filed) | Committee activity | Basis | Records |
|---|---|---|---|---|---|---|---|---|
| 2d after | 2023-11-10 | Tina Smith D-MN | AORT | buy | $50,001 – $100,000 | Senate Committee on Health, Education, Labor, and Pensions — 2023-11-08, 2 items | Medical Devices jurisdiction | filing · bill |
| 8d after | 2023-11-16 | Tina Smith D-MN | AORT | buy | $50,001 – $100,000 | Senate Committee on Health, Education, Labor, and Pensions — 2023-11-08, 2 items | Medical Devices jurisdiction | filing · bill |
| 12d after | 2019-04-09 | Tina Smith D-MN | ABT | sell | $250,001 – $500,000 | Senate Committee on Health, Education, Labor, and Pensions — 2019-03-28, 1 item | Pharmaceuticals & Biotech jurisdiction | filing · bill |
| 21d after | 2024-04-04 | Tina Smith D-MN | PODD | sell | $50,001 – $100,000 | Senate Committee on Health, Education, Labor, and Pensions — 2024-03-14, 1 item | Medical Devices jurisdiction | filing · bill |
| 26d before | 2023-11-16 | Tina Smith D-MN | AORT | buy | $50,001 – $100,000 | Senate Committee on Health, Education, Labor, and Pensions — 2023-12-12, 4 items | Medical Devices jurisdiction | filing · bill |
How these pairings are produced — the ±30-day window, the sector-to-jurisdiction map, and why routine bill referrals are excluded — is documented on Methodology. The term itself is defined in The Playbook.